TNF and pancreatic neuroendocrine tumor: The use of octreotide, a synthetic analogue of somatostatin, as the targeting ligand of the AAVP vector, provided the highly selective delivery of tumor necrosis factor α (TNF-α) to pancreatic neuroendocrine tumor cells expressing surface somatostatin receptors [76].